Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2124488rdf:typepubmed:Citationlld:pubmed
pubmed-article:2124488lifeskim:mentionsumls-concept:C0061202lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C0227651lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C1268567lld:lifeskim
pubmed-article:2124488lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:2124488pubmed:issue2lld:pubmed
pubmed-article:2124488pubmed:dateCreated1991-1-28lld:pubmed
pubmed-article:2124488pubmed:abstractTextProstaglandin production and cAMP formation are two signaling pathways identified for IL-1, though neither adequately account for the multitude of effects of IL-1. To investigate the role of tyrosine phosphorylation in IL-1 signaling, we used the tyrosine kinase inhibitor, genistein. At 10-30 micrograms/ml, genistein blocked IL-1 stimulated prostaglandin production and induction of prostaglandin endoperoxide synthase (PES) in glomerular mesangial cells maintained in 10% serum. Addition of genistein hours after IL-1 addition also halted further PGE2 synthesis. Genistein failed to block PES activity in vitro, indicating it was not acting as a PES inhibitor. Overall these data suggest that tyrosine phosphorylation may be a required event for IL-1 stimulation of PGE2 and PES activity, either directly as part of IL-1 signaling, or indirectly as part of a serum/PDGF competence effect on mesangial cells.lld:pubmed
pubmed-article:2124488pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:languageenglld:pubmed
pubmed-article:2124488pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:citationSubsetIMlld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2124488pubmed:statusMEDLINElld:pubmed
pubmed-article:2124488pubmed:monthDeclld:pubmed
pubmed-article:2124488pubmed:issn0006-291Xlld:pubmed
pubmed-article:2124488pubmed:authorpubmed-author:MorrisonA RARlld:pubmed
pubmed-article:2124488pubmed:authorpubmed-author:CoyneD WDWlld:pubmed
pubmed-article:2124488pubmed:issnTypePrintlld:pubmed
pubmed-article:2124488pubmed:day14lld:pubmed
pubmed-article:2124488pubmed:volume173lld:pubmed
pubmed-article:2124488pubmed:ownerNLMlld:pubmed
pubmed-article:2124488pubmed:authorsCompleteYlld:pubmed
pubmed-article:2124488pubmed:pagination718-24lld:pubmed
pubmed-article:2124488pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:meshHeadingpubmed-meshheading:2124488-...lld:pubmed
pubmed-article:2124488pubmed:year1990lld:pubmed
pubmed-article:2124488pubmed:articleTitleEffect of the tyrosine kinase inhibitor, genistein, on interleukin-1 stimulated PGE2 production in mesangial cells.lld:pubmed
pubmed-article:2124488pubmed:affiliationWashington University School of Medicine, Department of Medicine, St. Louis, Missouri 63110.lld:pubmed
pubmed-article:2124488pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2124488pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2124488pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2124488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2124488lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2124488lld:pubmed